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Summary. Recent years have seen tremendous changes in the modes of publication and dissemination of biomedical infor-
mation, with the introduction of countless new publishers and publishing models, as well as alternative modes of research 
evaluation. In parallel, we are witnessing an unsustainable explosion in the amount of information generated by each individual 
scientist, at the same time as many countries’ shrinking research budgets are greatly increasing the competition for research 
funding. In such a hypercompetitive environment, how does one measure excellence? This contribution will provide an 
overview of some of the ongoing changes in authorship practices in the biomedical sciences, and also the consequences of 
hypercompetition to the careers of young scientists, from the perspective of a tenured young faculty member in the biomedical 
sciences. It will also provide some suggestions as to alternate dissemination and evaluation practices that could reverse current 
trends. [Int Microbiol 18(4):253-261 (2015)]
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Introduction
Recent years have witnessed an explosion in the amount of 
scientific output produced by each individual researcher [12, 
43,56], creating major challenges for both scientists eager to 
keep up with the scientific literature, as well as for grant pan-
els and recruitment and promotion committees as they attempt 
to assess growing volumes of researcher productivity. These 
challenges were foreseen to some extent by Toffler [79]. This 
author introduced the concept of “information overload”, and 
we are very clearly witnessing this information overload in 
practice in the biomedical sciences today. For example, in any 
year in the period 2003–2012, there were about 3000–4000 
biomedical journals scholars had available to choose from 
when deciding where to send their works [28]. 
In 2009, there were 25,400 journals in science, technol-
ogy and medicine [9], with a projected annual growth of 3.5% 
[84] (which is probably currently larger due to the unfortunate 
explosion in predatory publishers [8]) and publishing about 
1.5 million scientific papers a year [9]. Additionally, as of 1st 
October 2015, PubMed contained >25 million citations to the 
biomedical literature [59]. This explosion in the total number 
of papers is in turn coupled with the increasing granularity of 
publications and of journals’ focus, leading in turn to a grow-
ing number of new journals targeting highly specialized sub-
fields of each discipline. 
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However, even though the amount of information we are 
required to follow and keep up with has exploded, the speed 
at which we can read the literature has not. For example, it has 
been suggested that the average specialist only would manage 
to read 322 papers a year [76]. However, based on both my 
personal experience and discussions with colleagues, I would 
venture to believe that the real number is most likely far 
lower. This impacts the modes of dissemination of informa-
tion, such that not only does readership become a collective 
effort [33], but also this can lead to many scientists becoming 
authors first, and readers second. This also means that being 
ignorant of 100% of the literature in your field is not actually 
very different from being ignorant of 98% of it [33], and the 
problem with this is that a lot of extremely valuable research 
can be lost in the noise.
The American Chemical Society (ACS) summed up the 
zeitgeist of the times in a recent article [5], and the ramifica-
tions of this change in publishing culture are dramatic for all 
scientists, and for young starting scientists in particular. Tying 
in with this, there has been a tremendous science policy push 
towards using “excellence” as a criterion in determining fund-
ing [15,37,40,49,70]. This in turn affects reward outcomes for 
young researchers, and, in its path, establishes an essentially 
new “social contract” for science [75]. For example, within 
Europe, both national and European level policies to promote 
excellent research have affected the organization of research 
[19–22,70], making it increasingly project-based.
This also affects the development of academic careers 
(which is increasingly directly correlated to grant income 
[72]) and the definition and operationalization of research ex-
cellence within universities. The latter is, again, increasingly, 
based exclusively on assessment criteria such as the amount of 
grants received, and on the number of highly cited articles in 
high-impact journals [38,41]). In such an information-flooded 
environment, therefore, how then do you measure and reward 
excellence, in biomedicine or any other discipline?
Author placement and research rewards
At the heart of all forms of scientific dissemination is author-
ship. Whether it is of scientific publications, reports, technical 
notes, or presentations, authorship is, in essence, the “cur-
rency” of academia [82]. It is used to measure research pro-
ductivity, it is also used as a basis for funding decisions and 
professional appointments, and it also brings direct rewards 
to the author, in terms of dissemination of work, new collabo-
rations, and greater collegiality. As such, therefore, the core 
aims of authorship are laudable and greatly beneficial to the 
scientific community. There are many cases, however, when 
the monetization and incentivization of authorship becomes 
questionable [21,22], as for example, in reports of Chinese 
universities that provide impact-factor-based monetary bo-
nuses upon the publication of manuscripts. These can be sev-
eral times higher than the average urban wage [60], which 
provides a tremendous incentive for fraud for even the most 
ethically oriented of researchers, although publication ethics 
are the responsibility of all parties involved in the publication 
process [83].
Other examples of problematic incentivization include 
personal accounts from several colleagues working at depart-
ments across Europe, whose departments have introduce arbi-
trary requirements of N publications before promotion to full 
Professor, without even taking into account differences in the 
publishing practices of various subfields (names and identities 
withheld for confidentiality). The biggest problem to arise out 
of this monetization of authorship, whether through direct fi-
nancial rewards or through using it as leverage for tenure and 
promotion, is that it encourages an explosion in the amount 
of scientific output, creating a drive towards the “least pub-
lishable unit” [17] style of publication, and completely over-
whelming the readership in the process.
The tight links between authorship and the reward system 
then also impacts the research process itself [62], turning the 
choice of what projects and collaborations are selected to a 
decision based on where the work is likely to be ultimately 
publishable, while optimizing for the minimum amount of 
work in a fixed time that will lead to the highest impact. This, 
in turn, affects the very core of doing research [39,62], as 
publication pressures affect study designs (non-risky topics, 
increasing chances of false positives), and convert scientific 
exchanges into a process designed mainly to secure a compet-
itive advantage [51,52,62], even in supposedly collaborative 
settings or in venues intended to advance the shared knowl-
edge of a field. As a result, the core work of knowledge pro-
duction is being cropped and tweaked to fit a narrow metric-
based evaluation system [19,29,62]. 
The next major challenge facing the assessment of indi-
vidual researchers is the fact that despite changes in research 
practices, author placement still drives many if not even most 
recruitment, tenure and funding decisions. In biomedical sci-
ences, this typically means that most credit is given to the first 
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and last author, although author positioning is very field de-
pendent. Additionally, and despite improvements, ghost author-
ships are still a major problem in biomedicine [53,74,86]. How-
ever, Science is not a solo enterprise, and with the increasing 
importance of interdisciplinarity [54], it is increasingly com-
mon to see papers in the literature with dozens if not hundreds 
of authors on it, following a long ongoing trend of increasing 
numbers of authors on scientific publications [61,80,91]. For 
instance, a 2007 publication in the journal Science listed 28 au-
thors, 7 of which were marked as having contributed equally 
[90]. However, one of these “authors” was the Wellcome Trust 
Case Consortium, which in fact brings the total author listing 
up to over 200 authors. An even more extreme incarnation of 
this can be seen in a recent paper in Physical Review Letters, 
which set the current authorship record with no less than 5154 
individual authors [1], comprising of 9 pages of actual science, 
and 24 pages of author names and institutions. A final example 
of direct relevance to biomedical research is a 2015 genomics 
paper that involved contributions from 900 undergraduate stu-
dents and listed 1000 authors in total [44].
Clearly, with author lists of these lengths, it can be ex-
tremely difficult to distinguish the added value each indi-
vidual author brings to the manuscript, and yet biomedical 
research assessment still puts a majority of emphasis on the 
contributions of first and last authors, including elite grants 
that only allow you to list your “main author” papers. This 
is particularly problematic taking also into account the fact 
that the number of authors on individual papers is constantly 
growing [61,80,91]. In addition, especially in interdisciplin-
ary research, even if there are only a few authors on the paper, 
the contribution of individual researchers from the different 
disciplines can be equally critical to the success of the project, 
and yet only one person can be first or last author respective-
ly. One easy way around this might seem to be to just move 
to an alphabetical author listing, however, even here there is 
trouble in paradise, as it has been demonstrated that in disci-
plines such as economics, where alphabetical author listing is 
the norm, each letter close to an A gives an increased chance 
of tenure at a top US department (and the associated profes-
sional recognition) [30]. Therefore, highlighting researcher 
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Fig. 1. Bubble plot illustrating the impact of biomedical journals in the years 2003–2012, on a logarithmic scale. The 
numerator of the plot shows the number of journal citations in 2012 to articles that were published in the years 2010 
and 2011, and the denominator of the plot is the absolute number of articles published in 2010 and 2011. All data were 
taken from Thomson Reuter’s Journal Citation Report. The figure has been kindly provided by Phil David from the 
Scholarly Kitchen, and was originally published at http://scholarlykitchen.sspnet.org/2013/07/24/dynamic-visualization-
of-biomedical-journals-2003-2012/ 
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contri butions in an effective way is absolutely critical [53,74, 
80,82,86]. There have, however, been positive moves in this 
direction. One example is the fact that an increasing number 
of institutions explicitly require applicants for recruitment or 
promotion to explicitly list their contributions to each of the 
publications on their publication lists. If executed with hon-
esty, this practice should reduce the incentive for ghost and 
honorary authorships. 
Additionally, an increasing number of journals are requir-
ing that not just author lists but also individual author contri-
butions be provided upon submission of an article, for pub-
lication with the final manuscript. The taxonomy for this can 
be as simple as “analyzed data”, “wrote paper”, “performed 
experiments”, but it can also become quite complex, as was 
for example the case in a 14-role taxonomy suggested by 
the publication Nature in 2014, which was based on corre-
spondence with 1200 authors and publishers of leading life 
sciences journals [4]. Examples of this taxonomy include, 
for example, “Study conception: ideas, formulation of re-
search question, statement of hypothesis”, or “Data cura-
tion: management activities to annotate (produce metadata) 
and maintain research data for initial use and later re-use”. 
According to Nature [4], this was generally well received, 
but is of course a small sample size and a very preliminary 
study. However, this is a promising direction that provides 
a much more streamlined template with which to assign au-
thor contributions and give appropriate credit where credit 
is due, rather than the rigid first/last authorship model being 
used in a lot of natural sciences today. By demanding explicit 
author contributions on published papers, the corresponding 
journals are significantly contributing to helping reduce the 
problem of “ghost” and “honorary” authorships, which make 
it even harder to assess genuine contributions on multi-author 
papers [82,83,86]. This move towards transparency should be 
lauded, as it will, hopefully, over time, create a scientific as-
sessment model that allows interdisciplinary research to be 
properly assessed [60], as well as fostering an environment 
of greater collaboration rather than competition for the most 
coveted positions on the author list.
Changing publication culture and mov-
ing away from bibliometrics
A 1987 manuscript, by one of the most eminent enzymolo-
gists of the 20th century, opens with the following text: “We 
report here an examination of the mechanisms of general acid 
and general base catalysis of the reactions of water and alco-
hols with acetaldehyde. These two mechanisms of catalysis 
are entirely different and are discussed separately; however, 
the work is described in a single long paper for economy of 
presentation of the experimental data” (italics mine for em-
phasis) [69]. For any scientist working in the life sciences 
today, no further comment is necessary to illustrate just how 
much publication culture has changed in the past three de-
cades. There has been much discussion in the recent litera-
ture about the uses and abuses of quantitative metrics such 
as the total number of citations, journal impact factors, or the 
ever-ubiquitous H-index (see e.g., refs. [13,14,18,29,45,50, 
65,68,85,89], among many others). Additionally, in chasing to 
publish their work in the highest impact journal possible, few 
researchers outside of the field of scientometrics are aware 
that the original purpose of journal impact factors (JIF) was 
never to assess individual researchers, but rather, to help li-
brarians decide what journals to purchase for institutional col-
lections [7] (see also ref. [34] for further information about 
the history of the JIF). 
Despite the concerns about uses and misuses of JIF, the 
information overload facing biomedical researchers in and of 
itself creates overdependence on bibliometrics, with JIF be-
coming synonymous with quality and being used to reduce 
complexity in the evaluation process by acting as an informa-
tion filter in search of relevant papers [26,87]. Recent research 
[62] has shown that the JIF is not only used in assessing of 
individual researchers, but also (and worryingly), impact fac-
tor considerations kick in at a very early stage in the research 
process long before researchers start to think about publish-
ing results. That is, JIF considerations have begun to structure 
work processes at the epistemic level, for instance affecting 
choices of which project to work on, or which laboratories to 
collaborate with, and so forth.
This makes moving away from bibliometrics-based cri-
teria complicated, and although much work has been done 
on the misuses of impact factors, things evolve in use when 
they are taken up in different research practices. As such, it is 
promising to see increased awareness of the problems with 
arbitrary metrics among scientists and research institutions, 
initiatives such as the San Francisco Declaration on Research 
Assessment (DORA) [64], and the push towards the devel-
opment of alternative metrics by which to assess researchers 
[10,11,14,57,67,88]. Additionally, citation counts and metrics 
such as the H-index are inherently flawed because they do not 
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tell you how many people are citing this paper as an example 
of bad work (they take into account negative as well as posi-
tive citations), and they can both over-exaggerate and harm 
the track records of achievements of scientists working at the 
interface of multiple disciplines with very disparate publish-
ing practices, depending on which discipline is performing the 
assessment. Therefore, quantitative metrics start having more 
limited usage in the assessment of interdisciplinary research, 
if discipline-dependent context is not taken into account. 
In addition to flooding the literature by pushing scientists 
to produce an inordinately large number of publications, such 
hypercompetition does not come without a cost to young sci-
entists. That is, as commented on recently by Alberts and col-
leagues [3], current Western research and authorship models 
are based on post-World War II concepts of constant growth. 
However, most biomedical research is done by an increas-
ing number of graduate students and postdocs, leading to 
an explosion in scientists at the bottom of the professional 
“pyramid”, and the amount of science that needs assessing. 
Therefore, scientific output has shot radically upwards at a 
time when research funding has gone down, and this has led 
to a toxically hypercompetitive environment, which can both 
put off even the most outstanding young scientists from an 
academic career, and puts undue pressure on established sci-
entists, taking their attention away from the goal of producing 
the highest quality research (see the discussion in ref. [3]).
From the perspective of the entire science system, this 
makes research over-dependent on what is essentially a huge 
PhD and postdoc “factory” [27,36,58] of cheap labor services 
[72,73], where only a very small portion of these researchers 
have the possibility to move up the academic ladder (for ex-
ample, according to the Royal Society, the figure for the UK 
for progression to professorial level in the natural sciences is 
only ca. 0.5% of all granted PhDs [77]. This is problematic 
in and of itself, because not everyone can or should be at the 
“top” of the research pyramid. Rather, we need an ecology of 
researchers working on different systems, and research group 
levels with different expertise and ambitions (to use a sports 
analogy, one would not want an entire football team to consist 
only of forward strikers).
Finally, while competition in general is good for science, 
as it leads to higher quality research, when taken too far, it 
suppresses creativity, collegiality and risk taking, characteris-
tics that are all essential for groundbreaking discoveries [3]. 
In addition, the growing pressure to publish in top journals 
leads more and more scientists to cut corners, exaggerate 
findings and overstate the significance of their work [3], as is 
observed not just in the explosion of journal retraction rates 
[25,71,81], but is also diligently covered in the popular blog 
Retraction Watch [http://retractionwatch.com]. The main im-
pact this has had on my work, and that of my colleagues, is 
that it also kills collaborative environments among one’s own 
team members, as graduate students and postdocs develop an 
“if I’m not first author what’s in it for me?” mentality, and it 
makes it harder and harder for them to work together. Clearly, 
this is not sustainable in the long term, and something has to 
change towards a healthier and more productive system if we, 
as a scientific community, want to continue producing excel-
lent science and training well-balanced young researchers.
How to identify and assess excellent 
young scientists?
A term that is increasingly used in grant applications and re-
cruitment panels is “excellence”, although this term in itself 
is quite vague. How does one define excellence? [55]. And, 
more critically, how does one get it right when assessing 
young scientists at the start of their careers, who may have 
little or no independent track record to draw on as of yet. In 
an aptly titled recent article [47], Loeb pointed out the prob-
lem that many prestigious universities are plagued with “dead 
wood” faculty who were exploding with promise when they 
were initially hired, while in parallel, there are many stories 
of scientists who do not receive tenure at their initial institu-
tions, move to “lesser” institutions, and still end up carrying 
the day. He argued that this is for a number of reasons, includ-
ing the tendency of senior scientists to push forward junior 
candidates who best replicate their own research and ideas, 
the fact that early career achievements are just a frozen snap-
shot of a researcher’s career, as well as over or under appre-
ciation of a faculty applicant that is a former graduate, due to 
again a frozen memory of the applicant’s achievements [47]. 
Hopefully, despite these problems, we do still manage to get 
recruitment of young candidates right most of the time. How-
ever, in light of the changing dynamics in publication and dis-
semination practices, current productivity-based assessment 
criteria clearly need re-addressing and updating to match cur-
rent modes of authorship and interdisciplinarity. 
As a thought experiment, I propose the reader to con-
sider two potential candidates that have made it to the very 
last stage of your hypothetical faculty search, both of whom 
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are research compatible with your top research department, 
and who have made a positive impression on the entire search 
committee. The first candidate is a postdoc from a world-
leading University, with a roster of famous mentors, extensive 
publication record, and several high impact publications. The 
second candidate comes from a smaller University, and from 
a country where funding for equipment and other research ex-
penses is scarce, and therefore has fewer publications, but has 
several nationally prestigious prizes and put in an exciting and 
novel research proposal. Who, then, would you pick for this 
faculty position? 
The knee-jerk response, of course, would be to take the 
first candidate. But at the start of their career, and with excel-
lent mentors, how much of a contribution did they really make 
to that work? Also, in the case of the second candidate, what 
if their lower output is due only to resources, and if you scale 
up to the resources that were available, what if they actually 
produced more when scaled for resources than the first can-
didate? If so, how much could they then achieve with a well-
funded start-up package and excellent graduate students? The 
choice is not straightforward, but it highlights the need to 
take into account contextualized researcher profiles when as-
sessing candidates for recruitment or high-profile grants and 
awards, rather than quantitative metrics. Clearly, fewer very 
good publications are superior to a large number of mediocre 
ones, and therefore it is important to actually read at least the 
top five publications flagged by the candidates to get a better 
idea of their research achievements (see also DORA). Man-
dating author contributions on publications lists submitted 
with tenure and promotion packages, and grant applications, 
allow the candidates to outline their contributions to each in-
dividual publication, in the case of multi-author papers.
Additionally, in terms of impact on the field, not just pub-
lications should be taken into account, but also other metrics 
such as patents, speaker invitations, awards, distinctions and 
also collaborative ability (“is this person going to be a good 
colleague?”). Finally, despite the push to always recruit the 
highest profile researchers that fulfill the criteria for (a very 
fluid definition of) excellence, once again, the need for an 
ecology rather than pyramid of researchers needs to be taken 
into account, as it is within such multi-dimensional research 
environments that the best quality research thrives and pro-
gresses.
There are, increasingly, other forms of dissemination of 
material, such as a new preprint server for the life sciences, 
bioaRxiv [http://bioRxiv.org], which has been modeled on 
the well-established and successful arXiv server in physics 
and mathematics [http://arXiv.org]; new modes of publication 
and peer review experimented with by for instance PLoS One 
[http://www.plosone.org/], F1000Research [http://f1000re-
search.com] and others, which include publishing based on 
soundness rather than impact, allowing reader comments and 
open peer review; new forms of metrics as implemented for 
example by new forms of measuring impact such as those 
provided by Impact Story [https://impactstory.org] and Alt-
Metrics [http://altmetrics.org, http://altmetric.com], and, re-
cently, a comprehensive manifesto on research evaluation, the 
“Leiden Manifesto” [42], which outlines a 10-point list to be 
taken into account in the evaluation of research. Irrespective 
of what particular direction the field takes, change needs to be 
made, and fast, to protect the futures of the next generation(s) 
of outstanding young researchers. 
Summary and outlook
I have written this Perspective not as a practitioner in scien-
tometrics, but from the personal perspective of a biomedical 
researcher very interested in questions surrounding research 
evaluation strategies. For economy of space there are many 
topics I have not touched on here, but as is the case also for 
other young scientists, I am personally affected by increasing 
hypercompetition. I am also, in particular, highly alarmed by 
the speed at which this is increasing, such that purely sub-
jectively, it appears that the pressure on the current genera-
tion of postdocs seeking faculty positions is already tremen-
dously larger than the already large pressure I faced only half 
a decade ago. The most tragic consequence of our current 
models, however, may well be how the current evaluation 
and reward system is eroding the “social” aspects of science 
[3,6,22,23,48], e.g., the collegiality principle, increasing com-
petitive struggles, blistering “benchmark masculinity” [78], 
and decreasing service to the scientific community [31]. In 
particular, some of the authorship and evaluation practices 
that have become central to academic work are in great ten-
sion with fostering innovative, collaborative and societally 
relevant science. Similarly, in the current research assessment 
models, even when the research comes from large charity 
funds (such as for instance cancer research foundations), the 
potential societal impact of the research (e.g., the effects on 
the clinic, potential new treatments) is usually not the main 
assessment criterion for determining the “value” of the re-
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search, or whether the money was well-spent. These tensions 
play a great role in creating the disillusionment and elevated 
stress levels facing academics [2,3,35,46,48,51,52,63], which 
surely contribute to driving some the best young scientists 
from the field.
There has been strong concern voiced by many others 
about the direction the field is taken, and as starting points 
I would recommend readers to turn to refs. [26,28,68,83,84] 
and references cited therein for further reading on this topic. 
Nevertheless, despite the great cause for concern, it is also 
promising to see the field take proactive measures to correct 
itself. The Leiden Manifesto [42] and DORA [64] are exam-
ples of this, as is proactive work to address these problems 
by many leading research organizations. Another promising 
step is that an increasing number of funding agencies request 
to see only a fixed number of your top publications, which 
creates a push towards quality over quantity in scientific pub-
lishing. Therefore, signs of change do exist, and there is cause 
to be hopeful. Ultimately, I have written this perspective be-
cause, while sustainable biomedical research can only come 
about at this stage through a major system overhaul at every 
level (research, funding, dissemination), we, the practitioners, 
are ultimately the ones who decide what Science will look 
like, and it is in our hands to fix it. 
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